CN102525981B - Propranolol hydrochloride tablets and preparation method thereof - Google Patents

Propranolol hydrochloride tablets and preparation method thereof Download PDF

Info

Publication number
CN102525981B
CN102525981B CN201210039145.3A CN201210039145A CN102525981B CN 102525981 B CN102525981 B CN 102525981B CN 201210039145 A CN201210039145 A CN 201210039145A CN 102525981 B CN102525981 B CN 102525981B
Authority
CN
China
Prior art keywords
ethanol
propranolol hydrochloride
preparation
solution
solid dispersion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210039145.3A
Other languages
Chinese (zh)
Other versions
CN102525981A (en
Inventor
王苏南
汤金春
周云飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHANGZHOU KANGPU PHARMACEUTICAL Co Ltd
Original Assignee
CHANGZHOU KANGPU PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGZHOU KANGPU PHARMACEUTICAL Co Ltd filed Critical CHANGZHOU KANGPU PHARMACEUTICAL Co Ltd
Priority to CN201210039145.3A priority Critical patent/CN102525981B/en
Publication of CN102525981A publication Critical patent/CN102525981A/en
Application granted granted Critical
Publication of CN102525981B publication Critical patent/CN102525981B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a preparation method for propranolol hydrochloride tablets. The method comprises the following steps of: 1) preparing a carrier for solid dispersoid, namely weighing 200 grams of polyethylene glycol (PEG) 6000, dissolving the PEG 6000 in 95 percent (ml/ml) ethanol to obtain an auxiliary material solution, dissolving 100 grams of propranolol hydrochloride in 95 percent (ml/ml) ethanol to obtain a main medicine solution, mixing the auxiliary material solution and the main medicine solution uniformly to obtain a mixed solution, and drying the mixed solution at temperature of between 35 and 55 DEG C under the vacuum with the vacuum degree of less than 10 Pa for 12 to 24 hours; 2) preparing tablets, namely crushing the materials obtained in the step 1), and sieving to obtain solid dispersoid powder; adding a formula dose of dextrin into the solid dispersoid powder, and putting the mixture into a granulator, performing dry mixing for 5 to 10 minutes, adding 40 to 50 percent ethanol serving as an adhesive, and granulating; sieving the materials with a 20-to-30-mesh sieve, granulating in the wet state, and transferring to a fluidized drying machine for drying until the moisture is 5 to 8 percent; and sieving the dried granules with a 20-to-30-mesh sieve, granulating, and mixing the obtained granules and a lubricating agent in a formula uniformly for tabletting.

Description

A kind of propranolol hydrochloride tablets and preparation method thereof
Technical field
The invention belongs to technical field of medicine, be specifically related to a kind of propranolol hydrochloride tablets preparation method.
Background technology
Propranolol hydrochloride is beta-receptor blockader, blocks myocardium beta receptor, and decreased heart rate suppresses cardiac contractile force and conduction, circulation volume minimizing, myocardial oxygen consumption reduction.The clinical arrhythmia that is mainly used in treating due to many reasons, also can be used for angina pectoris hypertension pheochromocytoma (pre-operative preparation) etc.
Although the uniformity of dosage units of common propranolol hydrochloride tablets is measured and is met pharmacopeia regulation according to the method for Chinese Pharmacopoeia appendix XE, but the absolute value A of the labelled amount stipulating in appendix XE and the difference of average is often larger, A+1.80S, close to 15, illustrates that the uniformity of dosage units of common propranolol hydrochloride tablet is not very good.Affect the homogeneity of product.
Measure dissolution according to the method for Chinese Pharmacopoeia appendix XC first method, common propranolol hydrochloride tablets stripping quantity is generally in 80% left and right, though meet the regulation of pharmacopeia " 75% that limit is labelled amount ", but still can further improve dissolution.
Summary of the invention
The present invention will solve all undesirable technical problems of common propranolol hydrochloride tablets uniformity of dosage units and dissolution, adopt PEG6000 to prepare propranolol hydrochloride solid dispersion as carrier, then be prepared into the agent of solid dispersion matrix, gained propranolol hydrochloride tablets agent content good evenness, dissolution can arrive the more than 90% of labelled amount, improve drug bioavailability, ensure drug quality.
A kind of propranolol hydrochloride tablets, write out a prescription as follows:
Supplementary material title Every 10,000 consumptions
Propranolol hydrochloride 100g
Dextrin 430g
PEG6000 200g
95% (ml/ml) ethanol 600-800ml
40~50% (ml/ml) ethanol In right amount
Lubricant 7.5g
Described lubricant is selected from magnesium stearate, micropowder silica gel or Pulvis Talci.
A kind of preparation method of propranolol hydrochloride tablets:
1), the preparation of solid dispersion carrier: take PEG6000200g and add 300-400ml 95% (ml/ml) ethanol and dissolve completely to PEG6000, obtain adjuvant solution; 100g propranolol hydrochloride is dissolved in 300-400ml 95% (ml/ml) ethanol winner drug solns; Adjuvant solution and principal agent solution mix homogeneously are obtained to mixed solution; By mixed solution vacuum drying 12-24 hour, vacuum is less than 10Pa, and temperature 35-55 ℃ controls moisture and is less than 1%;
2), tablet preparation: by step 1) gained crushing material, cross 100-120 mesh standard sieve and obtain solid dispersion powder; Gained solid dispersion powder, dextrin 430g are put into granulator, be dry mixed 5-10min, add the appropriate ethanol of 40~50% (ml/ml) moistening, setting shears frequency is 20-30Hz, shear granulation 5-10min; Material is crossed and is moved to boiling drier after the wet granulate of 20-30 mesh sieve and be dried to moisture 5-8%; Dried granule is crossed 20-30 mesh sieve granulate, and by the mix lubricant 5-10min in the granule obtaining and prescription, tabletting, obtains 10,000.
Technique effect of the present invention:
1, gained propranolol hydrochloride tablets adopts PEG6000 as solid dispersion carrier, and main component is distributed in carrier with molecularity, and uniformity of dosage units is greatly improved, and guarantees product homogeneity; Owing to selecting dextrin filler, dextrin has adsorption to principal agent, makes after solid dispersion, can eliminate dextrin to the effect of crude drug Molecular Adsorption, improve the stripping of medicine.
2, make the slice, thin piece making again after solid dispersion, quality homogeneous between batches between sheet and sheet.Dissolution rate is fast, contributes to improve bioavailability of drugs.
3, unilateral smooth, to make than the traditional handicraft brighter and cleaner brilliant white of tablet, increases patient compliance.
4, compressibility is good, only needs less pressure just can extrude hardness and friability and meets the tablet that pharmacopeia requires.
Accompanying drawing explanation
Propranolol hydrochloride tablets dissolution rate comparison prepared by propranolol hydrochloride tablets prepared by Fig. 1 applying solid dispersion technology of the present invention and common process;
In figure
Figure BDA0000137230480000021
represent propranolol hydrochloride tablets prepared by common process,
Figure BDA0000137230480000022
represent propranolol hydrochloride tablets prepared by applying solid dispersion technology.
The specific embodiment
Embodiment 1 propranolol hydrochloride tablets preparation method
1), the preparation of solid dispersion carrier: take PEG6000 200g and add 300mL95% (ml/ml) ethanol and dissolve completely to PEG6000, obtain adjuvant solution; 100g propranolol hydrochloride is dissolved in 300ml 95% (ml/ml) ethanol winner drug solns; Adjuvant solution and principal agent solution mix homogeneously are obtained to mixed solution; By mixed solution vacuum drying 12 hours, vacuum was less than 10Pa, and 35 ℃ of temperature are controlled moisture and are less than 1%;
2), tablet preparation: by step 1) gained crushing material, cross 100 mesh standard sieves and obtain solid dispersion powder; Gained solid dispersion powder, dextrin 430g are put into granulator, be dry mixed 5min, add 40% appropriate ethanol moistening, setting shears frequency is 20Hz, shear granulation 5min; Material is crossed and is moved to boiling drier after the wet granulate of 20 mesh sieves to be dried to moisture be 5%; Dried granule is crossed 20 mesh sieve granulate, and by the mix lubricant 5min in the granule obtaining and prescription, tabletting, obtains 10,000.Compressibility is good, only needs less pressure just can extrude hardness and friability and meets the tablet (seeing the following form 1) that pharmacopeia requires.
Table 1 compression force and hardness and friability relation
Compression force (KN) Hardness (Kg) Friability
4.1 5.5 0.5%
6.3 8.7 0.4%
9.8 12.2 0.1%
Embodiment 2 propranolol hydrochloride tablets preparation methoies
1), the preparation of solid dispersion carrier: take PEG6000200g and add 400ml 95% (ml/ml) ethanol to dissolve completely to PEG6000, obtain adjuvant solution; 100g propranolol hydrochloride is dissolved in 400ml 95% (ml/ml) ethanol winner drug solns; Adjuvant solution and principal agent solution mix homogeneously are obtained to mixed solution; By mixed solution vacuum drying 24 hours, vacuum was less than 10Pa, and 55 ℃ of temperature are controlled moisture and are less than 1%;
2), tablet preparation: by step 1) gained crushing material, cross 120 mesh standard sieves and obtain solid dispersion powder; Gained solid dispersion powder, dextrin 430g are put into granulator, be dry mixed 10min, add appropriate 50% ethanol moistening, setting shears frequency is 30Hz, shear granulation 10min; Material is crossed and is moved to boiling drier after the wet granulate of 30 mesh sieves and be dried to moisture 8%; Dried granule is crossed 30 mesh sieve granulate, and by the mix lubricant 10min in the granule obtaining and prescription, tabletting, obtains 10,000.Compressibility is good, only needs less pressure just can extrude hardness and friability and meets the tablet (seeing the following form 2) that pharmacopeia requires.
Table 2 compression force and hardness and friability relation
Figure BDA0000137230480000031
Figure BDA0000137230480000041
Embodiment 3 tablet quality inspections
1, outward appearance
Unilateral bright and clean, the Bai Liang of embodiment 1,2 gained propranolol hydrochloride tablets.
2, uniformity of dosage units
Embodiment 1,2 gained propranolol hydrochloride tablets are respectively got 10, and according to Chinese Pharmacopoeia, 2010 editions two appendix XE check uniformity of dosage units.Measure the every relative amount take labelled amount as 100, the average of getting 10 relative amounts.Embodiment 1, routine 2:A+1.84S are less than 5, and the uniformity of dosage units of gained propranolol hydrochloride tablets is good.
3, dissolution
Embodiment 1,2 gained propranolol hydrochloride tablets are respectively got 6, and according to Chinese Pharmacopoeia, 2010 editions two appendix XC check dissolution, and the stripping quantity that embodiment is 1,2 calculates all more than 90% according to labelled amount.(seeing accompanying drawing 1)
Take above-mentioned foundation desirable embodiment of the present invention as enlightenment, by above-mentioned description, relevant staff can, not departing from the scope of this invention technological thought, carry out various change and modification completely.The technical scope of this invention is not limited to the content in description, must determine its technical scope according to claim scope.

Claims (2)

1. a propranolol hydrochloride tablets, write out a prescription as follows:
supplementary material title every 10,000 consumptions propranolol hydrochloride 100g dextrin 430g pEG6000 200g 95% (ml/ml) ethanol 600-800ml 40~50% (ml/ml) ethanol in right amount lubricant 7.5g.
2. the preparation method of propranolol hydrochloride tablets described in claim 1:
1), the preparation of solid dispersion carrier: take PEG6000 200g and add 400ml 95% (ml/ml) ethanol to dissolve completely to PEG6000, obtain adjuvant solution; 100g propranolol hydrochloride is dissolved in 200ml 95% (ml/ml) ethanol winner drug solns; Adjuvant solution and principal agent solution mix homogeneously are obtained to mixed solution; By mixed solution vacuum drying 12-24 hour, vacuum is less than 10Pa, and temperature 35-55 ℃ controls moisture and is less than 1%;
2), tablet preparation: by step 1) gained crushing material, cross 100-120 mesh standard sieve and obtain solid dispersion powder; Gained solid dispersion powder, dextrin 430g are put into granulator, be dry mixed 5-10min, add the appropriate ethanol of 40~50% (ml/ml) moistening, setting shears frequency is 20-30Hz, shear granulation 5-10min; Material is crossed and is moved to boiling drier after the wet granulate of 20-30 mesh sieve and be dried to moisture 5-8%; Dried granule is crossed 20-30 mesh sieve granulate, and by the mix lubricant 5-10min in the granule obtaining and prescription, tabletting, obtains 10,000.
CN201210039145.3A 2012-02-21 2012-02-21 Propranolol hydrochloride tablets and preparation method thereof Active CN102525981B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210039145.3A CN102525981B (en) 2012-02-21 2012-02-21 Propranolol hydrochloride tablets and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210039145.3A CN102525981B (en) 2012-02-21 2012-02-21 Propranolol hydrochloride tablets and preparation method thereof

Publications (2)

Publication Number Publication Date
CN102525981A CN102525981A (en) 2012-07-04
CN102525981B true CN102525981B (en) 2014-05-21

Family

ID=46334815

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210039145.3A Active CN102525981B (en) 2012-02-21 2012-02-21 Propranolol hydrochloride tablets and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102525981B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106822002A (en) * 2015-12-03 2017-06-13 康普药业股份有限公司 A kind of Propranolol Hydrochloride pharmaceutical composition
CN113288877A (en) * 2021-05-27 2021-08-24 常州康普药业有限公司 Method for preparing dipyridamole dispersible tablets

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1602849A (en) * 2004-08-23 2005-04-06 南昌弘益科技有限公司 Propranolol hydrochloride drop pills and its preparation method
CN101496792A (en) * 2008-01-30 2009-08-05 中国科学院上海药物研究所 Punailuoer or delayed-release preparation of salt thereof and preparation method thereof
CN101721351A (en) * 2008-10-22 2010-06-09 黄文武 Solid dispersion of bystolic or pharmaceutical salt of bystolic, preparation method thereof and use thereof
CN101766629A (en) * 2008-12-26 2010-07-07 北京琥珀光华医药科技开发有限公司 Propranolol compound preparation and preparation method thereof
CN101987082A (en) * 2010-07-16 2011-03-23 钟术光 Solid preparation and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1602849A (en) * 2004-08-23 2005-04-06 南昌弘益科技有限公司 Propranolol hydrochloride drop pills and its preparation method
CN101496792A (en) * 2008-01-30 2009-08-05 中国科学院上海药物研究所 Punailuoer or delayed-release preparation of salt thereof and preparation method thereof
CN101721351A (en) * 2008-10-22 2010-06-09 黄文武 Solid dispersion of bystolic or pharmaceutical salt of bystolic, preparation method thereof and use thereof
CN101766629A (en) * 2008-12-26 2010-07-07 北京琥珀光华医药科技开发有限公司 Propranolol compound preparation and preparation method thereof
CN101987082A (en) * 2010-07-16 2011-03-23 钟术光 Solid preparation and preparation method thereof

Also Published As

Publication number Publication date
CN102525981A (en) 2012-07-04

Similar Documents

Publication Publication Date Title
CN102579381B (en) Guanidine hydrochloride sustained release preparation and preparation method thereof
CN102908327B (en) Sustained release preparation for ivabradine or medicinal salt thereof
CN102949372A (en) Nicergoline pill and preparation method thereof
CN103070864B (en) Repaglinide and metformin hydrochloride medicinal composition and its preparation method
CN107184559A (en) A kind of diabecron sustained-release tablet and preparation method thereof
CN101851247B (en) Composition containing clopidogrel bisulfate crystal particles
CN103610658B (en) Immunomodulator slow-release preparation and preparation method thereof
CN106983726B (en) Azilsartan tablets and preparation method thereof
CN103479592A (en) Metformin hydrochloride sustained release tablets and preparation method thereof
CN104523615B (en) A kind of Sulpiride tablet and preparation method thereof
CN102525981B (en) Propranolol hydrochloride tablets and preparation method thereof
CN107753455B (en) A tablet containing imidafenacin and its preparation method
CN102349915B (en) Acetaminophen, caffeine, chlorphenamine maleate, and vitamin C preparation and preparation method thereof
CN102764254B (en) A kind of levetiracetam medicinal composition and preparation method thereof
CN102462663A (en) Felodipine pharmaceutical composition based on dry process granulation
CN102755300A (en) Voriconazole composition and preparation method thereof
CN106109428B (en) The preparation process of Repaglinide melbine
CN105395506A (en) Clonidine hydrochloride sustained-release tablet
JP5755382B2 (en) Orally disintegrating tablets
CN104666265B (en) A kind of promethazine hydrochloride tablet and preparation method thereof
CN104666263B (en) A kind of tablet containing Levetiracetam and preparation method thereof
CN105030707B (en) Method for preparing clotrimazole buccal tablets based on modified glucose whole powder direct compression method
CN103356495A (en) Letrozole tablet and preparation method thereof
CN104983705B (en) Sodium Prasterone Sulfate sustained release tablets and preparation method thereof
CN104367562A (en) Pramipexole dihydrochloride slow-release tablets and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant